
zzso zzso human zzso zzso was first used as a replacement therapy in patients bearing zzso zzso in the zzso zzso In this indication, it was shown since 1999 to be very efficient in inducing a dramatic weight loss in rare children and adults with severe obesity due to the lack of zzso These first clinical trials clearly showed that zzso acted centrally to reduce food zzso inducing loss of fat mass, and to correct zzso zzso immune and neuroendocrine zzso A few years later, zzso was also shown to reverse the zzso complications associated with zzso zzso due to primary defects in fat storage, which induce zzso zzso The beneficial effects, which could be zzso by central and/or peripheral mechanisms, are thought to mainly involve the lowering effects of zzso on zzso zzso storage, in particular in liver and muscles, reducing insulin zzso Interestingly, zzso therapy also reversed the zzso axis zzso associated with zzso zzso However, if zzso treatment has been shown to be dramatically efficient in zzso states, its very limited effect in inducing weight loss in common obese patients revealed that, in patients with adequate zzso zzso mechanisms of zzso resistance and zzso tolerance prevent zzso from inducing any additional zzso This review will present the current data about the effects of zzso therapy in humans, and discuss the recent perspectives of this therapy in new zzso 

